Cargando…
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of vir...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724424/ https://www.ncbi.nlm.nih.gov/pubmed/34993157 http://dx.doi.org/10.3389/fcimb.2021.725035 |
_version_ | 1784625904818847744 |
---|---|
author | Chatterjee, Sanchari Datey, Ankita Sengupta, Soumya Ghosh, Arup Jha, Atimukta Walia, Safal Singh, Sharad Suranjika, Sandhya Bhattacharya, Gargee Laha, Eshna Keshry, Supriya Suman Ray, Amrita Pani, Sweta Smita Suryawanshi, Amol Ratnakar Dash, Rupesh Senapati, Shantibhusan Beuria, Tushar K. Syed, Gulam Hussain Prasad, Punit Raghav, Sunil Kumar Devadas, Satish Swain, Rajeeb K. Chattopadhyay, Soma Parida, Ajay |
author_facet | Chatterjee, Sanchari Datey, Ankita Sengupta, Soumya Ghosh, Arup Jha, Atimukta Walia, Safal Singh, Sharad Suranjika, Sandhya Bhattacharya, Gargee Laha, Eshna Keshry, Supriya Suman Ray, Amrita Pani, Sweta Smita Suryawanshi, Amol Ratnakar Dash, Rupesh Senapati, Shantibhusan Beuria, Tushar K. Syed, Gulam Hussain Prasad, Punit Raghav, Sunil Kumar Devadas, Satish Swain, Rajeeb K. Chattopadhyay, Soma Parida, Ajay |
author_sort | Chatterjee, Sanchari |
collection | PubMed |
description | PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of viral infection. METHODS: Samples were collected from six asymptomatic and six symptomatic SARS-CoV-2-confirmed hospitalized patients in Bhubaneswar, Odisha, India. Clinical details, biochemical parameters, and treatment regimen were collected from a hospital; viral load was determined by RT-PCR; and the levels of cytokines and circulating antibodies in plasma were assessed by Bio-Plex and isotyping, respectively. In addition, whole-genome sequencing of viral strains and mutational analysis were carried out. RESULTS: Analysis of the biochemical parameters highlighted the increased levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), serum SGPT, serum SGOT, and ferritin in symptomatic patients. Symptomatic patients were mostly with one or more comorbidities, especially type 2 diabetes (66.6%). The virological estimation revealed that there was no significant difference in viral load of oropharyngeal (OP) samples between the two groups. On the other hand, viral load was higher in plasma and serum samples of symptomatic patients, and they develop sufficient amounts of antibodies (IgG, IgM, and IgA). The levels of seven cytokines (IL-6, IL-1α, IP-10, IL-8, IL-10, IFN-α2, IL-15) were found to be highly elevated in symptomatic patients, while three cytokines (soluble CD40L, GRO, and MDC) were remarkably higher in asymptomatic patients. The whole-genome sequence analysis revealed that the current isolates were clustered with 19B, 20A, and 20B clades; however, 11 additional changes in Orf1ab, spike, Orf3a, Orf8, and nucleocapsid proteins were acquired. The D614G mutation in spike protein is linked with higher virus replication efficiency and severe SARS-CoV-2 infection as three patients had higher viral load, and among them, two patients with this mutation passed away. CONCLUSIONS: This is the first comprehensive study of SARS-CoV-2 patients from India. This will contribute to a better understanding of the pathophysiology of SARS-CoV-2 infection and thereby advance the implementation of effective disease control strategies. |
format | Online Article Text |
id | pubmed-8724424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87244242022-01-05 Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India Chatterjee, Sanchari Datey, Ankita Sengupta, Soumya Ghosh, Arup Jha, Atimukta Walia, Safal Singh, Sharad Suranjika, Sandhya Bhattacharya, Gargee Laha, Eshna Keshry, Supriya Suman Ray, Amrita Pani, Sweta Smita Suryawanshi, Amol Ratnakar Dash, Rupesh Senapati, Shantibhusan Beuria, Tushar K. Syed, Gulam Hussain Prasad, Punit Raghav, Sunil Kumar Devadas, Satish Swain, Rajeeb K. Chattopadhyay, Soma Parida, Ajay Front Cell Infect Microbiol Cellular and Infection Microbiology PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of viral infection. METHODS: Samples were collected from six asymptomatic and six symptomatic SARS-CoV-2-confirmed hospitalized patients in Bhubaneswar, Odisha, India. Clinical details, biochemical parameters, and treatment regimen were collected from a hospital; viral load was determined by RT-PCR; and the levels of cytokines and circulating antibodies in plasma were assessed by Bio-Plex and isotyping, respectively. In addition, whole-genome sequencing of viral strains and mutational analysis were carried out. RESULTS: Analysis of the biochemical parameters highlighted the increased levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), serum SGPT, serum SGOT, and ferritin in symptomatic patients. Symptomatic patients were mostly with one or more comorbidities, especially type 2 diabetes (66.6%). The virological estimation revealed that there was no significant difference in viral load of oropharyngeal (OP) samples between the two groups. On the other hand, viral load was higher in plasma and serum samples of symptomatic patients, and they develop sufficient amounts of antibodies (IgG, IgM, and IgA). The levels of seven cytokines (IL-6, IL-1α, IP-10, IL-8, IL-10, IFN-α2, IL-15) were found to be highly elevated in symptomatic patients, while three cytokines (soluble CD40L, GRO, and MDC) were remarkably higher in asymptomatic patients. The whole-genome sequence analysis revealed that the current isolates were clustered with 19B, 20A, and 20B clades; however, 11 additional changes in Orf1ab, spike, Orf3a, Orf8, and nucleocapsid proteins were acquired. The D614G mutation in spike protein is linked with higher virus replication efficiency and severe SARS-CoV-2 infection as three patients had higher viral load, and among them, two patients with this mutation passed away. CONCLUSIONS: This is the first comprehensive study of SARS-CoV-2 patients from India. This will contribute to a better understanding of the pathophysiology of SARS-CoV-2 infection and thereby advance the implementation of effective disease control strategies. Frontiers Media S.A. 2021-12-21 /pmc/articles/PMC8724424/ /pubmed/34993157 http://dx.doi.org/10.3389/fcimb.2021.725035 Text en Copyright © 2021 Chatterjee, Datey, Sengupta, Ghosh, Jha, Walia, Singh, Suranjika, Bhattacharya, Laha, Keshry, Ray, Pani, Suryawanshi, Dash, Senapati, Beuria, Syed, Prasad, Raghav, Devadas, Swain, Chattopadhyay and Parida https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Chatterjee, Sanchari Datey, Ankita Sengupta, Soumya Ghosh, Arup Jha, Atimukta Walia, Safal Singh, Sharad Suranjika, Sandhya Bhattacharya, Gargee Laha, Eshna Keshry, Supriya Suman Ray, Amrita Pani, Sweta Smita Suryawanshi, Amol Ratnakar Dash, Rupesh Senapati, Shantibhusan Beuria, Tushar K. Syed, Gulam Hussain Prasad, Punit Raghav, Sunil Kumar Devadas, Satish Swain, Rajeeb K. Chattopadhyay, Soma Parida, Ajay Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title | Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title_full | Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title_fullStr | Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title_full_unstemmed | Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title_short | Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
title_sort | clinical, virological, immunological, and genomic characterization of asymptomatic and symptomatic cases with sars-cov-2 infection in india |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724424/ https://www.ncbi.nlm.nih.gov/pubmed/34993157 http://dx.doi.org/10.3389/fcimb.2021.725035 |
work_keys_str_mv | AT chatterjeesanchari clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT dateyankita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT senguptasoumya clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT ghosharup clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT jhaatimukta clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT waliasafal clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT singhsharad clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT suranjikasandhya clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT bhattacharyagargee clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT lahaeshna clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT keshrysupriyasuman clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT rayamrita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT paniswetasmita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT suryawanshiamolratnakar clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT dashrupesh clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT senapatishantibhusan clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT beuriatushark clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT syedgulamhussain clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT prasadpunit clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT raghavsunilkumar clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT devadassatish clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT swainrajeebk clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT chattopadhyaysoma clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia AT paridaajay clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia |